Vittorio Bellotti Selected Research

Amyloidogenic Proteins

10/2018	The interaction of β2-microglobulin with gold nanoparticles: impact of coating, charge and size.
1/2016	D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile.
4/2012	Structure, stability, and aggregation of β-2 microglobulin mutants: insights from a Fourier transform infrared study in solution and in the crystalline state.
3/2012	A recurrent D-strand association interface is observed in β-2 microglobulin oligomers.
8/2008	Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue.
4/2008	Sulfonated molecules that bind a partially structured species of beta2-microglobulin also influence refolding and fibrillogenesis.
11/2005	Search of ligands for the amyloidogenic protein beta2-microglobulin by capillary electrophoresis and other techniques.
4/2004	Pharmaceutical strategies against amyloidosis: old and new drugs in targeting a "protein misfolding disease".

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vittorio Bellotti Research Topics

Disease

56	Amyloidosis 01/2022 - 03/2002
9	Amyloid Plaque 12/2021 - 04/2004
4	Cardiomyopathies (Cardiomyopathy) 12/2021 - 04/2016
4	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2015
4	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2019 - 10/2004
4	Alzheimer Disease (Alzheimer's Disease) 09/2013 - 10/2005
3	Pain (Aches) 04/2022 - 09/2013
3	Transthyretin-Related Hereditary Amyloidosis 12/2021 - 09/2013
3	Renal Insufficiency (Renal Failure) 01/2016 - 07/2010
2	Inflammation (Inflammations) 01/2022 - 04/2006
2	Disease Progression 12/2019 - 09/2015
2	Stroke (Strokes) 11/2010 - 04/2006
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 11/2010 - 10/2005
2	Proteostasis Deficiencies 12/2008 - 04/2004
1	Osteitis 04/2022
1	Polyneuropathies (Polyneuropathy) 12/2020
1	Parkinsonian Disorders (Parkinsonism) 12/2019
1	Immunoglobulin Light-chain Amyloidosis 01/2017
1	Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy) 04/2016
1	Apolipoprotein C-III Deficiency 01/2016
1	Astrocytoma (Pilocytic Astrocytoma) 01/2014
1	Neuroblastoma 01/2014
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 09/2013
1	Rheumatic Diseases (Rheumatism) 10/2009
1	Cognitive Dysfunction 04/2009
1	Osteoarthritis 04/2009
1	Hypoalphalipoproteinemias (Hypoalphalipoproteinemia) 12/2006
1	Atherosclerotic Plaque (Atheroma) 12/2006
1	Acidosis 05/2006
1	Necrosis 04/2006
1	Cerebral Infarction 04/2006
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2006
1	Myocardial Infarction 04/2006

Drug/Important Bio-Agent (IBA)

38	Amyloid (Amyloid Fibrils)IBA 01/2022 - 03/2002
29	Proteins (Proteins, Gene)FDA Link 03/2021 - 04/2004
13	Prealbumin (Transthyretin)IBA 12/2021 - 05/2004
8	Amyloidogenic ProteinsIBA 10/2018 - 04/2004
6	Apolipoprotein A-I (Apolipoprotein A1)IBA 04/2011 - 01/2003
5	Blood Proteins (Serum Proteins)IBA 12/2021 - 05/2004
3	SynucleinsIBA 01/2020 - 01/2015
3	Pharmaceutical PreparationsIBA 12/2019 - 04/2004
3	Serum Amyloid P-ComponentIBA 11/2010 - 04/2004
2	AA amyloidosisIBA 01/2022 - 10/2009
2	AntibodiesIBA 01/2019 - 11/2010
2	Peptides (Polypeptides)IBA 01/2018 - 08/2008
2	Lysine (L-Lysine)FDA Link 12/2017 - 02/2007
2	Doxycycline (Periostat)FDA LinkGeneric 09/2013 - 01/2011
2	Complement System Proteins (Complement)IBA 11/2010 - 04/2006
2	Proline (L-Proline)FDA Link 11/2010 - 05/2009
2	ApolipoproteinsIBA 08/2008 - 12/2006
2	CollagenIBA 02/2008 - 06/2006
1	Serine Proteases (Serine Protease)IBA 12/2021
1	Fibrinolysin FDA Link 12/2021
1	Protein Subunits (Protein Subunit)IBA 12/2021
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 12/2021
1	Apolipoproteins AIBA 11/2021
1	apolipoprotein A-IV (apolipoprotein AIV)IBA 11/2021
1	TrypsinIBA 11/2021
1	Protein Sorting Signals (Signal Peptide)IBA 11/2021
1	Glucosylceramidase (Glucocerebrosidase)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 12/2019
1	alpha-SynucleinIBA 12/2019
1	Congo RedIBA 01/2019
1	SolutionsIBA 03/2018
1	oleuropeinIBA 01/2018
1	Formaldehyde (Formol)FDA Link 12/2017
1	Therapeutic UsesIBA 01/2017
1	LipidsIBA 01/2017
1	Lipoproteins (Lipoprotein)IBA 01/2016
1	Apolipoprotein C-IIIIBA 01/2016
1	Protein AggregatesIBA 01/2016
1	SilverIBA 01/2014
1	Histocompatibility Antigens Class IIBA 10/2013
1	Molecular Chaperones (Chaperone, Molecular)IBA 06/2011
1	Crystallins (Crystallin)IBA 06/2011
1	Glycoproteins (Glycoprotein)IBA 11/2010
1	pyrrolidineIBA 05/2009
1	Carboxylic AcidsIBA 05/2009
1	AmidesIBA 01/2009
1	Biological ProductsIBA 12/2008
1	polyacrylamideIBA 08/2008
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 08/2008
1	Protein Isoforms (Isoforms)IBA 08/2008
1	ProteomeIBA 08/2008
1	Heparin (Liquaemin)FDA LinkGeneric 02/2008
1	HDL LipoproteinsIBA 12/2006
1	CholesterolIBA 12/2006
1	Amino Acids FDA Link 12/2006
1	1,6-bis(phosphocholine)-hexaneIBA 04/2006
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 04/2006
1	C-Reactive ProteinIBA 04/2006
1	LigandsIBA 04/2006

Therapy/Procedure

8	Renal Dialysis (Hemodialysis) 04/2015 - 11/2005
5	Therapeutics 04/2022 - 11/2010
1	Drug Therapy (Chemotherapy) 01/2017
1	Length of Stay 05/2016
1	Operative Time 05/2016
1	Cell- and Tissue-Based Therapy (Cell Therapy) 09/2010
1	Lasers (Laser) 08/2008
1	Ligation 04/2006